Global AI in Medical Imaging Market Outlook, 2031

The global AI in medical imaging market is emerging as a significant area of healthcare technology, transforming how medical images are acquired, analyzed, interpreted, and integrated into clinical workflows. Artificial intelligence is increasingly being applied to radiology, pathology, cardiology, oncology, neurology, and other imaging-intensive specialties to support image reconstruction, segmentation, detection, classification, diagnosis, workflow prioritization, and clinical decision-making. The market is supported by collaboration among healthcare providers, medical-imaging manufacturers, technology companies, research institutions, and professional associations such as the Radiological Society of North America (RSNA), which promotes research, education, standards, and responsible use of imaging technologies. Regulatory authorities are also developing frameworks to ensure the safety, effectiveness, transparency, and reliability of AI-enabled medical devices. In the United States, the U.S. Food and Drug Administration (FDA) oversees AI-enabled medical devices through its medical-device regulatory framework and has issued guidance addressing the development and lifecycle management of machine-learning-enabled devices. The National Institute of Standards and Technology (NIST) also provides voluntary frameworks for managing AI-related risks. In Europe, the European Commission's AI Act establishes a risk-based framework for artificial intelligence, while the Medical Device Regulation provides requirements relevant to AI-enabled medical devices. These regulatory developments are encouraging manufacturers and healthcare organizations to strengthen clinical validation, cybersecurity, data governance, and post-market monitoring. Future opportunities are expected through the integration of AI with advanced imaging modalities, multimodal foundation models, cloud-based radiology, automated reporting, personalized medicine, and real-world clinical data. AI-powered image analysis could increasingly support earlier disease detection, workflow prioritization, treatment planning, and remote diagnostic services. The global AI in medical imaging market is experiencing strong growth as healthcare providers, imaging centers, medical-device manufacturers, and technology companies increasingly adopt artificial intelligence to improve image interpretation, diagnostic workflows, and clinical decision-making. The competitive landscape includes established medical technology companies such as Siemens Healthineers, GE HealthCare, Philips, and Canon Medical Systems, alongside specialized AI companies including Aidoc, Tempus, Viz.ai, and HeartFlow. Competition is increasingly focused on developing AI solutions for radiology, cardiology, oncology, neurology, pathology, and other imaging-intensive specialties. Companies are differentiating themselves through advanced image-analysis algorithms, automated detection and segmentation, clinical decision-support capabilities, cloud-based platforms, and integration with existing picture archiving and communication systems and electronic health records. Strategic partnerships between AI developers, hospitals, diagnostic centers, medical-imaging manufacturers, and research institutions are becoming an important competitive strategy because clinical validation and workflow integration are essential for successful adoption. Market growth is being supported by increasing demand for earlier disease detection, rising imaging volumes, shortages of specialized radiology expertise, and the need to improve diagnostic efficiency and workflow prioritization. A notable competitive shift is occurring from standalone algorithms designed for individual abnormalities toward comprehensive AI platforms capable of supporting multiple imaging tasks and clinical workflows. Multimodal AI is also emerging as an important area, enabling systems to combine medical images with clinical histories, laboratory information, and other patient data. Companies are increasingly emphasizing regulatory clearance, clinical evidence, cybersecurity, interoperability, and explainability to strengthen market acceptance. Market Dynamics Market Drivers • Increasing demand for faster and more accurate diagnosis: Healthcare systems are experiencing growing demand for medical imaging across radiology, oncology, cardiology, neurology, and other specialties. AI can assist clinicians by automatically detecting abnormalities, segmenting anatomical structures, classifying findings, and prioritizing potentially urgent cases. As AI algorithms become more capable and clinically validated, their use is expected to expand from basic detection toward comprehensive diagnostic and treatment-planning support. • Growing adoption of digital imaging and advanced imaging technologies: The increasing digitization of healthcare and widespread use of modalities such as MRI, CT, X-ray, ultrasound, PET, and mammography are creating larger volumes of digital medical images suitable for AI analysis. Combining imaging data with clinical, genomic, laboratory, and patient-history information could enable more personalized and comprehensive diagnosis. Market Challenges • Data quality, standardization, and bias: AI models require large, diverse, and accurately labeled datasets. Medical images can vary significantly according to imaging equipment, acquisition protocols, patient populations, institutions, and geographic regions. Greater interoperability, standardized datasets, diverse training populations, and external validation are required to improve reliability and reduce algorithmic bias. • Regulatory, clinical validation, and trust issues: AI-enabled medical imaging tools can influence clinical decisions, making safety, effectiveness, transparency, and regulatory compliance particularly important. Developers need to demonstrate that their algorithms perform reliably in real-world clinical environments. Healthcare professionals also need confidence that AI recommendations can be appropriately interpreted and verified. Market Trends • Shift toward multimodal and integrated AI: Medical imaging AI is moving beyond analyzing images independently toward systems capable of combining images with clinical notes, laboratory results, patient histories, and other healthcare information. Multimodal AI can provide a more comprehensive patient context and potentially improve clinical decision support, disease characterization, and treatment planning. • Expansion from detection to workflow and clinical decision support: Earlier AI applications primarily focused on detecting specific abnormalities. The market is increasingly moving toward solutions that support the entire imaging workflow, including image acquisition, reconstruction, triage, reporting, follow-up, and treatment planning. AI can help prioritize urgent examinations, automate measurements and reporting tasks, reduce repetitive work, and support radiologists throughout the diagnostic process. Segment Analysis The global AI in medical imaging market can be segmented by technology into deep learning, natural language processing (NLP), and others. Deep learning is the most prevalent technology segment, largely because medical imaging applications depend heavily on computer vision and pattern-recognition capabilities. Deep learning models can analyze complex images, identify abnormalities, segment anatomical structures, classify findings, and support disease detection across radiology and other imaging specialties. These capabilities have made deep learning particularly relevant for applications involving CT, MRI, X-ray, mammography, and ultrasound. NLP represents an increasingly important complementary technology, particularly where imaging information needs to be combined with clinical reports, patient histories, physician notes, or other unstructured medical information. NLP can support automated report analysis, information extraction, clinical documentation, and integration of imaging findings into broader clinical workflows. The others category includes technologies such as computer vision techniques, machine learning algorithms, reinforcement learning, and emerging generative AI approaches. A notable trend shift is the movement from standalone image-analysis algorithms toward multimodal AI systems that combine image understanding with textual and clinical information. Generative AI and foundation models are also influencing the market by enabling automated reporting, image reconstruction, synthetic data generation, and more flexible image interpretation. Another important development is the integration of AI directly into imaging equipment and clinical software platforms, allowing algorithms to operate closer to the point of image acquisition and interpretation. The global AI in medical imaging market can be segmented by application into neurology, respiratory and pulmonary, cardiology, breast screening, orthopedics, and others. Cardiology and neurology are among the most prominent application areas, reflecting the extensive use of medical imaging for detecting and monitoring complex diseases affecting the heart, brain, and vascular system. In neurology, AI is increasingly used for stroke detection, brain-tumor assessment, neurodegenerative disease evaluation, and analysis of structural and functional brain images. In cardiology, AI can support cardiac imaging, cardiovascular risk assessment, vessel analysis, and identification of abnormalities in imaging studies. Respiratory and pulmonary applications are also significant, particularly for analyzing chest X-rays and CT scans to identify lung abnormalities and support disease assessment. Breast screening continues to benefit from AI-assisted mammography analysis, while orthopedics uses AI for bone, joint, and musculoskeletal imaging assessment. A notable trend shift is the move from AI systems designed to detect a single abnormality toward multi-disease and multi-organ platforms capable of supporting several clinical tasks within the same workflow. Multimodal AI is further expanding applications by combining medical images with clinical histories, laboratory information, and radiology reports. Another emerging trend is the use of AI for workflow prioritization, automated measurements, follow-up comparison, and treatment planning rather than diagnosis alone. The global AI in medical imaging market can be segmented by modality into CT scan, MRI, X-rays, ultrasound, and nuclear imaging. X-rays and CT scans represent highly prevalent modalities for AI adoption, supported by their widespread clinical use and the large volume of images generated across hospitals and diagnostic centers. AI can assist with detection, classification, segmentation, image enhancement, workflow prioritization, and automated reporting for X-ray and CT examinations. CT is particularly suitable for AI applications because it provides detailed anatomical information and is widely used in oncology, cardiology, neurology, and emergency care. MRI is another important modality, with AI increasingly applied to image reconstruction, noise reduction, segmentation, lesion detection, and workflow optimization. AI can potentially help improve MRI efficiency and support interpretation of complex anatomical and functional information. Ultrasound is gaining attention because AI can assist with image acquisition, interpretation, measurements, and operator guidance, potentially supporting broader access to imaging expertise. Nuclear imaging represents a more specialized application area, where AI can assist with image reconstruction, quantitative analysis, disease characterization, and treatment planning. A major trend shift is the movement from AI focused solely on image interpretation toward end-to-end imaging intelligence, including acquisition, reconstruction, enhancement, analysis, reporting, and follow-up. Generative AI and foundation models are also being explored for automated reporting and multimodal interpretation. Cloud-based AI platforms are further enabling algorithms to be deployed across different imaging environments. The global AI in medical imaging market can be segmented by end use into hospitals, diagnostic imaging centers, and others. Hospitals represent the most prevalent end-use segment, primarily because they perform a broad range of imaging procedures across emergency care, oncology, cardiology, neurology, orthopedics, and other specialties. Hospitals are increasingly adopting AI to support image interpretation, prioritize urgent cases, automate measurements, improve reporting workflows, and assist clinical decision-making. Integration with picture archiving and communication systems, radiology information systems, and electronic health records is becoming an important factor influencing adoption. Diagnostic imaging centers are also increasingly incorporating AI into their operations, particularly for automated image analysis, quality improvement, workflow management, and reporting support. These centers can benefit from AI technologies that help manage high imaging workloads while maintaining consistency in diagnostic processes. The others category includes specialty clinics, academic medical institutions, research organizations, and ambulatory healthcare facilities. A notable trend shift is the movement from pilot-based AI deployments toward enterprise-wide integration, where healthcare organizations incorporate multiple AI applications into their imaging infrastructure rather than using isolated algorithms. Cloud-based deployment is also expanding opportunities for diagnostic centers and smaller healthcare organizations that may have limited internal computing resources. Another emerging trend is the development of AI platforms capable of supporting multiple modalities and clinical specialties through a single integrated environment. Regional Analysis North America North America is a leading region in the global AI in medical imaging market, supported by advanced healthcare infrastructure, strong adoption of digital imaging, extensive AI research, and the presence of major medical technology and AI companies. The U.S. is particularly prominent, with hospitals and diagnostic providers increasingly adopting AI for radiology, cardiology, oncology, and neurology. Regulatory development, clinical validation, and partnerships between healthcare organizations and technology companies are further supporting market development. Europe Europe represents a well-established and steadily expanding market, supported by advanced healthcare systems, medical research capabilities, and strong medical-device and pharmaceutical industries. Countries such as Germany, the U.K., France, and the Nordic nations are increasingly exploring AI for medical imaging interpretation, workflow optimization, and clinical decision support. The region's focus on data protection, AI governance, interoperability, and medical-device regulation is shaping how imaging AI technologies are developed and implemented. Asia Pacific Asia Pacific is an important growth region for AI in medical imaging, driven by expanding healthcare infrastructure, increasing imaging volumes, digital transformation, and government support for artificial intelligence. China, Japan, India, South Korea, Singapore, and Australia are developing AI capabilities across radiology, oncology, cardiology, and other specialties. Growing healthcare demand and shortages of specialized medical expertise are encouraging the use of AI to improve diagnostic efficiency and extend access to imaging support. South America South America represents an emerging market, with Brazil serving as an important center for healthcare technology and medical research. Increasing healthcare digitization and adoption of diagnostic imaging are creating opportunities for AI-based image analysis and workflow automation. However, differences in healthcare infrastructure, investment availability, access to advanced technology, and specialized AI expertise can limit adoption. Partnerships with international technology companies, hospitals, and research institutions could help strengthen regional capabilities. Middle East and Africa The Middle East and Africa represent a developing but promising market. Gulf countries are investing in advanced healthcare infrastructure, digital hospitals, medical technology, and artificial intelligence as part of broader healthcare modernization initiatives. AI medical imaging has opportunities in radiology, oncology, cardiology, and remote diagnostic services. In Africa, AI could help address shortages of specialized imaging expertise and improve access to diagnostic services. However, infrastructure limitations, funding constraints, data availability, connectivity, and shortages of trained professionals remain important barriers. Key Developments • January 2026: Aidoc announced U.S. FDA clearance for its comprehensive foundation model AI for medical imaging, covering 11 new abdominal CT indications in a single workflow. • In April 2025, Spark Radiology launched a cloud-based workflow platform for radiologists in India to streamline imaging operations and reporting. The platform integrates AI-powered tools for automated case triage, structured reporting, and collaboration, enhancing diagnostic accuracy and efficiency. • March 2025: Microsoft expanded its healthcare AI models portfolio at HIMSS, adding fine-tuning capabilities for MedImageInsight, a multimodal foundation model spanning 14 medical imaging modalities, alongside CXRReportGen for image-to-report generation. • February 2025: the Madras Medical Mission (MMM) in Chennai launched an AI-powered cardiac care center equipped with advanced imaging technologies, including a state-of-the-art cath lab offering AI-driven diagnostics for angioplasty and stenting. The AI algorithms enhance diagnosis accuracy by identifying angiogram blockages and abnormalities, improving treatment planning and patient outcomes. • February 2025: Coreline Soft, a South Korean medical imaging AI company, launched in Australia through a partnership with ParagonCare to support major hospitals in the National Lung Cancer Screening Program. • January 2024: GE HealthCare announced an acquisition agreement with MIM Software from Cleveland, a global provider of medical imaging analysis and AI solutions in molecular radiotherapy, radiation oncology, urology, and diagnostic imaging. The acquisition aims to integrate MIM Software's imaging analytics and digital workflow capabilities across diverse care areas, enhancing innovation and distinguishing GE HealthCare's solutions to positively impact patients and healthcare systems globally. • November 2023: GE HealthCare announced its AI suite, MyBreastAI, at the RSNA 2023 conference. This innovative product helps streamline radiologists' workflows, offering them advanced tools to identify and diagnose breast cancer at earlier stages, ultimately improving patient outcomes. Considered in this report • Historic Year: 2020 • Base Year: 2025 • Estimated Year: 2026 • Forecast Year: 2031 Aspects covered in this report • Global AI in Medical Imaging Market with its value and forecast along with its segments • Various drivers and challenges • Ongoing trends and developments • Top profiled companies • Strategic recommendation By Technology • Deep Learning • Natural Language Processing (NLP) • Others By Application • Neurology • Respiratory and Pulmonary • Cardiology • Breast Screening • Orthopedics • Others By Modality • CT Scan • MRI • X-rays • Ultrasound • Nuclear Imaging By End-Use • Hospitals • Diagnostic Imaging Centers • Others

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Ask an Expert

Sikandar Kesari

Research Analyst

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now